While much of the focus remains on its impact on neurophysiological processes, there is growing curiosity about its broader implications across diverse biological systems. This article aims to explore ...

近日， 永州市中心医院冷水滩院区泌尿外科 成功为一罕见的库欣综合征——双侧肾上腺大结节增生导致的ACTH非依赖性皮质醇增多症患者实施了腹腔镜下左侧肾上腺切除术，标志着永州市中心医院在复杂肾上腺疾病的诊治上又迈出了坚实的一步。

多囊卵巢综合症的出现，对女性的危害也特别严重，不但会影响到身体的健康，而且还会让女性美丽不在，我们要重视日常生活当中合理的预防。 多囊卵巢综合症危害 ...

Fetal growth restriction (FGR) is defined as a pathological in utero growth disorder primarily caused by factors related to ...

自闭症的出现，让好多家长特别痛苦，它对孩子也是一种严重的疾病，我们要清楚致病的因素，而且在日常的生活当中也要对孩子进行合理的调理。 自闭症原因 ...

圣地亚哥 - Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) 已向美国食品和药物管理局（FDA）提交了paltusotine的新药申请（NDA）。Paltusotine是一种针对肢端肥大症的新型治疗选择。这种药物是每日一次的口服疗法，专门针对2型生长抑素受体，这一点很重要，因为它为目前作为标准治疗的注射疗法提供了潜在的替代选择。

王先生就像是一个“疯子”，拿命在工作；每一次听到同事说这些，王先生都会笑一笑说，“趁现在还算年轻，多拼一拼，以后老了，想干都干不动了。”然而，最近的一次体检，彻底打破了王先生平静的生活，他的LDL-C水平竟然高达5.3mmol/升！

Beyond neuroprotection, Semax has attracted interest as a potential support for cognitive function. This aspect of the ...

SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) ...

BridgeBio Pharma released Phase 1/2 trial results for BBP-631, its gene therapy for congenital adrenal hyperplasia. The study ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...

It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing’s disease.